Moderna, Bayer-Backed Startup Metagenomi Files for US IPO

Reuters01-07

Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the United States on Friday.

The startup, launched in 2018 by UC Berkeley scientists, joins a slew of companies gearing up for a 2024 listing after a stock rally in recent months.

Growing expectations that the Federal Reserve could guide the economy to a soft landing is boosting confidence after a dismal spell late last year.

Earlier this week, KKR-backed BrightSpring Health Services also submitted paperwork for a Nasdaq listing.

Metagenomi is developing therapies for genetic diseases. All of its revenue has been generated from three collaboration agreements, including one with Moderna, and not any product sales.

For the nine months ended Sept. 30, its collaboration revenue surged nearly three-fold, to $32.36 million.

Loss was $48.96 million in the same period, compared to $28.97 million a year earlier.

Metagenomi will aim to list on the Nasdaq under the symbol "MGX". J.P.Morgan, Wells Fargo and Jefferies are among the underwriters for the IPO.

The filing comes a year after the Emeryville, California-based company raised $275 million in a private funding round.

Moderna rose over 2% on Friday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

2

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2401128685?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-01-07 08:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2401128685","market":"us","top_or_hot":-1,"title":"Moderna, Bayer-Backed Startup Metagenomi Files for US IPO","media":"Reuters","content":"<html><head></head><body><p>Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the United States on Friday.</p><p>The startup, launched in 2018 by UC Berkeley scientists, joins a slew of companies gearing up for a 2024 listing after a stock rally in recent months.</p><p>Growing expectations that the Federal Reserve could guide the economy to a soft landing is boosting confidence after a dismal spell late last year.</p><p>Earlier this week, KKR-backed BrightSpring Health Services also submitted paperwork for a Nasdaq listing.</p><p>Metagenomi is developing therapies for genetic diseases. All of its revenue has been generated from three collaboration agreements, including <a href=\"https://laohu8.com/S/AONE.U\">one</a> with Moderna, and not any product sales.</p><p>For the nine months ended Sept. 30, its collaboration revenue surged nearly three-fold, to $32.36 million.</p><p>Loss was $48.96 million in the same period, compared to $28.97 million a year earlier.</p><p>Metagenomi will aim to list on the Nasdaq under the symbol &#34;MGX&#34;. J.P.Morgan, Wells Fargo and Jefferies are among the underwriters for the IPO.</p><p>The filing comes a year after the Emeryville, California-based company raised $275 million in a private funding round.</p><p>Moderna rose over 2% on Friday.</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna, Bayer-Backed Startup Metagenomi Files for US IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna, Bayer-Backed Startup Metagenomi Files for US IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-01-07 08:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the United States on Friday.The startup, launched in 2018 by UC ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4532","symbol_name":"文艺复兴科技持仓","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2401128685","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2401128685","pubTimestamp":1704587387,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the United States on Friday.The startup, launched in 2018 by UC Berkeley scientists, joins a slew of companies gearing up for a 2024 listing after a stock rally in recent months.Growing expectations that the Federal Reserve could guide the economy to a soft landing is boosting confidence after a dismal spell late last year.Earlier this week, KKR-backed BrightSpring","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4532":"文艺复兴科技持仓","BK4548":"巴美列捷福持仓","BK4551":"寇图资本持仓","MRNA":"Moderna, Inc.","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","BK4501":"段永平概念","BK4588":"碎股","BK4139":"生物科技","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)"},"translate_title":"拜尔支持的初创公司宏基因组为美国首次公开募股提供文件","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Metagenomi Technologies, a genetic medicines company backed by Bayer Healthcare and Moderna, filed for an initial public offering in the United States on Friday.The startup, launched in 2018 by UC Berkeley scientists, joins a slew of companies gearing up for a 2024 listing after a stock rally in recent months.Growing expectations that the Federal Reserve could guide the economy to a soft landing is boosting confidence after a dismal spell late last year.Earlier this week, KKR-backed BrightSpring Health Services also submitted paperwork for a Nasdaq listing.Metagenomi is developing therapies for genetic diseases. All of its revenue has been generated from three collaboration agreements, including one with Moderna, and not any product sales.For the nine months ended Sept. 30, its collaboration revenue surged nearly three-fold, to $32.36 million.Loss was $48.96 million in the same period, compared to $28.97 million a year earlier.Metagenomi will aim to list on the Nasdaq under the symbol \"MGX\". J.P.Morgan, Wells Fargo and Jefferies are among the underwriters for the IPO.The filing comes a year after the Emeryville, California-based company raised $275 million in a private funding round.Moderna rose over 2% on Friday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2401128685"}